Invention Grant
- Patent Title: Triazolinone compounds as HNE inhibitors
-
Application No.: US15375281Application Date: 2016-12-12
-
Publication No.: US09890169B2Publication Date: 2018-02-13
- Inventor: Elisabetta Armani , Carmelida Capaldi
- Applicant: CHIESI FARMACEUTICI S.P.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP15199816 20151214
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P11/06 ; A61P11/08 ; A61P17/06 ; A61P37/08
Abstract:
Triazolinone compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the therapy of diseases and conditions in which HNE is implicated.
Public/Granted literature
- US20170166574A1 NOVEL COMPOUNDS Public/Granted day:2017-06-15
Information query
